Home » Tenders » Europe » Germany » Open House Contracts for Several Active Substances / Combinations of Active Substances Tender

Open House Contracts for Several Active Substances / Combinations of Active Substances Tender

Download Documents

AOK NORDWEST - THE HEALTH INSURANCE COMPANY has floated a tender for Open House Contracts for Several Active Substances / Combinations of Active Substances. The project location is Germany and the tender is closing on 30 Apr 2022. The tender notice number is 276045-2020, while the TOT Ref Number is 43495782. Bidders can have further information about the Tender and can request the complete Tender document by Registering on the site.

Procurement Summary

Country : Germany

Summary : Open House Contracts for Several Active Substances / Combinations of Active Substances

Deadline : 30 Apr 2022

Other Information

Notice Type : Tender

TOT Ref.No.: 43495782

Document Ref. No. : 276045-2020

Competition : ICB

Financier : Self Financed

Purchaser Ownership : -

Tender Value : Refer Document

Purchaser's Detail

Purchaser : AOK NORDWEST - THE HEALTH INSURANCE COMPANY
Address: Copenhagener Strasse 1
Town: Dortmund
NUTS code: DEA - NORTH RHINE WESTPHALIA
Postal Code: 44269
Germany
Email :openhouse@nw.aok.de
URL :www.aok.de

Tender Details

Document Type: Contract notice

Title: Open house contracts for several active substances / combinations of active substances

Reference Number: 2020-06-11-NW-SAW

Contract Type: Supplies

Description: The subject of this publication is the conclusion of contracts in accordance with Section 130a (8) SGB V for the following active substances / combinations of active substances as part of a so-called open-house process:

- silodosin (G04CA04);

- Erlotinib (L01XE03);

- Leuprorelin (L02AE02 & H01CA04);

- somatropin (H01AC01);

- Tolvaptan (ATC G04BX21);

- Tolvaptan (ATC C03XA01);

- indacaterol & glycopyrronium bromide (ATC R03AL04);

- perindopril & indapamide (ATC C09BA54);

- Tobramycin (ATC J01GB01);

- dalteparin (ATC B01AB04);

- sulfasalazine (ATC M01CX02);

- Tapentadol (ATC N02AX06).

Providing uniform contractual terms and a uniform access procedure, all suitable and interested pharmaceutical companies or communities of pharmaceutical companies are offered the conclusion of a discount contract in accordance with Section 130a (8) SGB V for the active substances / combinations of active substances mentioned.

The earliest contract start is August 1st, 2020. Of which a ...